PER 6.90% 8.1¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK, page-12

  1. 1,713 Posts.
    lightbulb Created with Sketch. 117
    I have a feeling that momentum is starting to build here. A broom through the old management, new expectations set. Tier 1 staff coming on board - that can help the old staff that are still around see a new way of working.

    say, do, say, do. building trust. slow steady delivery from competent people.

    long may it last.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.006(6.90%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $154.2K 1.820M

Buyers (Bids)

No. Vol. Price($)
2 33824 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 275242 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.